Drugs & TargetsFree Caris Life Sciences submits two PMA applications to FDA for whole exome and whole transcriptome sequencing May 08, 2020Vol.46 No.19
Drugs & TargetsFree FDA approves GSK’s PARP inhibitor Zejula for first-line maintenance of advanced ovarian cancer May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants accelerated approval to new dosing regimen for Keytruda May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants Mobocertinib Breakthrough Therapy Designation in NSCLC designation May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants accelerated approval for Trodelvy in previously-treated metastatic TNBC April 24, 2020Vol.46 No.17
Drugs & TargetsFree FDA approves first targeted treatment for patients with cholangiocarcinoma April 24, 2020Vol.46 No.17
